Doctor Karan Bami

St. Michael's Hospital, Toronto (Canada)

Follow

Contributor content

Effects of empagliflozin on cardiac function in patients with type 2 diabetes mellitus: echocardiographic substudy of the EMPA-HEART cardiolink-6 trial

Presentation

Effects of empagliflozin on cardiac function in patients with type 2 diabetes mellitus: echocardiographic substudy of the EMPA-HEART cardiolink-6 trial

ESC 365 is supported by

novartis

Explore sponsored resources